Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib

被引：7
作者：
Piper-Vallillo, Andrew J. [1 ,2 ,3 ]
Sequist, Lecia V. [2 ,3 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Massachusetts Gen Hosp, 55 Fruit St,BHX-1-125, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
来源：
JACC: CARDIOONCOLOGY | 2019年 / 1卷 / 02期
关键词：
cardiotoxicity; EGFR; NSCLC; osimertinib;
D O I：
10.1016/j.jaccao.2019.11.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：179 / 181
页数：3
相关论文
共 12 条
  • [1] Osimertinib-Induced Cardiotoxicity A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)
    Anand, Kartik
    Ensor, Joe
    Trachtenberg, Barry
    Bernicker, Eric H.
    [J]. JACC: CARDIOONCOLOGY, 2019, 1 (02): : 172 - 178
  • [2] [Anonymous], 2019, ANN ONCOL S5
  • [3] ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer
    de Marinis, Filippo
    Wu, Yi-Long
    de Castro Jr, Gilberto
    Chang, Gee-Chen
    Chen, Yuh-Min
    Cho, Byoung Chul
    Freitas, Helano C.
    Jiang, Liyan
    Kim, Sang-We
    Martin, Claudio
    Metro, Giulio
    Provencio, Mariano
    Vansteenkiste, Johan
    Vicente, David
    Zhou, Qing
    Miranda, Miguel F.
    Bakker, Nicolaas A.
    Rigas, James R.
    Cheema, Parneet K.
    [J]. FUTURE ONCOLOGY, 2019, 15 (26) : 3003 - 3014
  • [4] AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
    Jaenne, Pasi A.
    Yang, James Chih-Hsin
    Kim, Dong-Wan
    Planchard, David
    Ohe, Yuichiro
    Ramalingam, Suresh S.
    Ahn, Myung-Ju
    Kim, Sang-We
    Su, Wu-Chou
    Horn, Leora
    Haggstrom, Daniel
    Felip, Enriqueta
    Kim, Joo-Hang
    Frewer, Paul
    Cantarini, Mireille
    Brown, Kathryn H.
    Dickinson, Paul A.
    Ghiorghiu, Serban
    Ranson, Malcolm
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18) : 1689 - 1699
  • [5] Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
    Mok, T. S.
    Wu, Y. -L.
    Ahn, M. -J.
    Garassino, M. C.
    Kim, H. R.
    Ramalingam, S. S.
    Shepherd, F. A.
    He, Y.
    Akamatsu, H.
    Theelen, W. S. M. E.
    Lee, C. K.
    Sebastian, M.
    Templeton, A.
    Mann, H.
    Marotti, M.
    Ghiorghiu, S.
    Papadimitrakopoulou, V. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) : 629 - 640
  • [6] FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
    Odogwu, Lauretta
    Mathieu, Luckson
    Goldberg, Kirsten B.
    Blumenthal, Gideon M.
    Larkins, Erin
    Fiero, Mallorie H.
    Rodriguez, Lisa
    Bijwaard, Karen
    Lee, Eunice Y.
    Philip, Reena
    Fan, Ingrid
    Donoghue, Martha
    Keegan, Patricia
    McKee, Amy
    Pazdur, Richard
    [J]. ONCOLOGIST, 2018, 23 (03) : 353 - 359
  • [7] Oyakawa Takuya, 2017, J Thorac Oncol, V12, pe159, DOI 10.1016/j.jtho.2017.05.016
  • [8] CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
    Reungwetwattana, Thanyanan
    Nakagawa, Kazuhiko
    Cho, Byoung Chul
    Cobo, Manuel
    Cho, Eun Kyung
    Bertolini, Alessandro
    Bohnet, Sabine
    Zhou, Caicun
    Lee, Ki Hyeong
    Nogami, Naoyuki
    Okamoto, Isamu
    Leighl, Natasha
    Hodge, Rachel
    McKeown, Astrid
    Brown, Andrew P.
    Rukazenkov, Yuri
    Ramalingam, Suresh S.
    Vansteenkiste, Johan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (33) : 3290 - +
  • [9] Current perspective: Osimertinib-induced QT prolongation: new drugs with new side-effects need careful patient monitoring
    Schiefer, Mart
    Hendriks, Lizza E. L.
    Trang Dinh
    Lalji, Ulrich
    Dingemans, Anne-Marie C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 91 : 92 - 98
  • [10] Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
    Soria, J. -C.
    Ohe, Y.
    Vansteenkiste, J.
    Reungwetwattana, T.
    Chewaskulyong, B.
    Lee, K. H.
    Dechaphunkul, A.
    Imamura, F.
    Nogami, N.
    Kurata, T.
    Okamoto, I.
    Zhou, C.
    Cho, B. C.
    Cheng, Y.
    Cho, E. K.
    Voon, P. J.
    Planchard, D.
    Su, W. -C.
    Gray, J. E.
    Lee, S. -M.
    Hodge, R.
    Marotti, M.
    Rukazenkov, Y.
    Ramalingam, S. S.
    Boyer, Michael
    Lee, Chee
    Hughes, Brett
    O'Byrne, Kenneth
    Briggs, Peter
    Milward, Michael
    John, Thomas
    Demedts, Ingel
    Vansteenkiste, Johan
    Bustin, Frederique
    Barrios, Carlos Henrique
    Timcheva, Constanta
    Butts, Charles
    Goss, Glenwood
    Juergens, Rosalyn
    Leighl, Natasha
    Cheng, Susanna
    Burkes, Ronald
    Zhou, Caicun
    Zhang, Helong
    Shu, Yongqian
    Cheng, Ying
    Zhou, Qing
    Li, Wei
    Feng, Guosheng
    He, Yong
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02) : 113 - 125
12